Burkitt lymphoma (BL) is an uncommon, highly aggressive B-cell Non-Hodgkin lymphoma, constituting 1.2% of Non-Hodgkin lymphoid neoplasms in the United States [1]. Many patients are cured with first...
No takes yet. Share an insight, caveat, or question.
Seitter et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: